Kailos Genetics, Inc.

HUNTSVILLE, AL · Founded 2010 · CIK 0001503871 · Medtech · Acquired

Genetic testing and analysis platform for precision medicine insights

kailosgenetics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.9M
7 Form D · Apr 2018
102 months since last filing
Contracts
—
No federal contracts on record
Patents
4
2 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,500,000
Private capital raisedForm D · SEC$1,900,000
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$2,500,000
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$2,000,000
Private capital raisedForm D · SEC$1,975,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
961INOVISE MEDICAL INC—$5.8M
962My Music Machines Inc.——
963908 Devices Inc.—$64M
964Kailos Genetics, Inc.—$3.9M
965SEEUS95 INC——
966TecTraum, Inc.—$3.8M
967Butterfly Health, Inc.—$8.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Randall BachmeyerExecutive Officer
  • James HudsonDirector
  • James Hudson, Jr.Director
  • David MooreDirector · Executive Officer
  • Kenneth NoonanDirector
  • Brian PollockDirector · Executive Officer
  • Katherine VarleyDirector
  • Cheri WalkerExecutive Officer
  • Michael WaltersDirector · Executive Officer
  • Danny WindhamDirector

Patents

USPTO · 2 granted of 4

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.